ERBB2 and gastric cancer: Furthermore, HOTAIR was revealed to be capable of positively modulating human epithelial growth factor receptor 2 (HER2) in GC by competing for miR-331-3p binding, a miRNA with different target specificities for both HOTAIR and HER2.